The analysis of the GBM sub group with no copy number alterations revealed that the upregulation of ANRIL is largely restricted to GBMs with no copy number alterations in INK4b/ARF/INK4a locus (Supplementary Figure 7A). The gene discussed is CDKN2B; the disease is glioblastoma.